MedTrace Logo

Effect of Topically-Applied Hyaluronic-Acid on Palatal Epithelial Wound Closure

NCT02534415 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2015-08-27

No results posted yet for this study

Summary

Aim of the study is to assess the therapeutic effects of topical hyaluronic-acid use on secondary wound healing of the free gingival graft donor site. The hypothesis of this study is that topical hyaluronic-acid gel has positive effects on secondary wound healing of free gingival graft donor site by reducing pain, burning sensation, and accelerating the healing.

Conditions

  • Wound Healing Complication

Interventions

DRUG

Periodontal dressing material

Procedure:Palatal wound area was covered with periodontal dressing material at baseline and 3rd day

DRUG

0.2% Hyaluronic acid gel

0.2% topical hyaluronic-acid gel was applied to palatal wound area and covered with periodontal dressing material (Peripac®) at baseline and 3rd day

DRUG

0.8% Hyaluronic acid gel

0.8% topical hyaluronic-acid gel was applied palatal wound area and covered with periodontal dressing material (Peripac®) at baseline and 3rd day

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Bahar Kuru, Prof. Dr. · Marmara University, Faculty of Denistry, Department of Periodontology

  • Başak Doğan, Prof. Dr. · Marmara University, Faculty of Denistry, Department of Periodontology

  • Hatice Selin Yıldırım, Dr. · Marmara University, Faculty of Denistry, Department of Periodontology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-07-31
Completion
2015-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02534415 on ClinicalTrials.gov